| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Dendreon Interest Remains Extremely High
Posted on 05/22/2007 18:22:12 | Link | Post Comment
by Jon C. Ogg
247 Wall St.
Since Dendreon (DNDN) has gotten a bit of life this week, there have been numerous inquiries as to "Where is this stock going?" from stock investors.
There is obviously some hope by investors that the activists will be able to push the FDA into approving Provenge for late-stage prostate cancer. The fact that an activist group has started Provengenow.org probably says it all. It is not yet known who started Provengenow.org's web site because the registrar is actually "MyPrivateRegistration" if you look up the domain owner. This web site has actually become more full with more data even since yesterday. What is becoming more obvious is that Dendreon "may" find itself as winner because of "cancer patient activism" rather than investor activism. This activist group was also noted yesterday on CNBC and this helped the bullish scenario's fight yesterday.
Continue article at 247WallSt.com
RELATED READING:
- Dendreon's New Double-Twist
- Dendreon, the Day That Could Have Been and What to Expect Now
- Rantasorous Rx
___________________
247 Wall St.
Since Dendreon (DNDN) has gotten a bit of life this week, there have been numerous inquiries as to "Where is this stock going?" from stock investors. There is obviously some hope by investors that the activists will be able to push the FDA into approving Provenge for late-stage prostate cancer. The fact that an activist group has started Provengenow.org probably says it all. It is not yet known who started Provengenow.org's web site because the registrar is actually "MyPrivateRegistration" if you look up the domain owner. This web site has actually become more full with more data even since yesterday. What is becoming more obvious is that Dendreon "may" find itself as winner because of "cancer patient activism" rather than investor activism. This activist group was also noted yesterday on CNBC and this helped the bullish scenario's fight yesterday.
Continue article at 247WallSt.com
RELATED READING:
- Dendreon's New Double-Twist
- Dendreon, the Day That Could Have Been and What to Expect Now
- Rantasorous Rx
___________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Millionaire Now! by Larry Nusbaum
- Ludwig von Mises Institute
- Credit Bloggers
- Don't Mess With Taxes
- Invest2Success
- Poor and Stupid
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Fri Jul 18, 2008 08:23AM
U.S. stock futures rebound on Citigroup results"S&a [read more]
U.S. stock futures rebound on Citigroup results"S&a [read more]
<< My Home | TheMoneyBlogs Home